Q2 Pharma Private Limited
About Q2 Pharma Private Limited
Data last updated:
Q2 Pharma Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 24 November 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2022PTC407366. Its GSTIN is 10AAACQ8693C1ZM (Bihar).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Prity Kumari and Dipti Kumari.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C/O Chanchal Jha First Floor Khasra No.123 Gali No.13 Wazirabad, Delhi, India – 110084.
As per the financials filed for FY 2024, the company reported a revenue of ₹65.71 Lakh. For the same year it recorded a net profit of ₹7,392 (net margin 0.1%) and EBITDA of ₹7,392 (EBITDA margin 0.1%).
The company has about 8 employees on its provident fund (EPFO) records.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Chanchal Jha First Floor Khasra No.123 Gali No.13 Wazirabad, Delhi, India – 110084
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Q2 Pharma Private Limited
The main business activity of Q2 Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Q2 Pharma Private Limited FY 2024 filings available
Q2 Pharma Private Limited reported revenue of ₹65.71 Lakh for FY 2024.
Financial Statement Summary of Q2 Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹7,392 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹7,392 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Q2 Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 0.1% | •••• |
| Net Profit Margin | 0.1% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Q2 Pharma are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Q2 Pharma Private Limited
Q2 Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Capsutab Drugs Private Limited | ₹65.74 Lakh (FY 2023) | •••• | •••• | 419.0% | •••• | Panchkula, Haryana, India |
| Samant Hospitech Private Limited | ₹65.74 Lakh (FY 2021) | •••• | •••• | •••• | Thane, Maharashtra, India | |
| Salutary Softech Private Limited | ₹65.74 Lakh (FY 2021) | •••• | •••• | -29.0% | •••• | Delhi, India |
| Abkin Dealcomm Private Limited | ₹65.73 Lakh (FY 2021) | •••• | •••• | 109.0% | •••• | Howrah, West Bengal, India |
| Zatami Gourmet Private Limited | ₹65.73 Lakh (FY 2024) | •••• | •••• | -29.0% | •••• | Hyderabad, Telangana, India |
| Q2 Pharma Private Limited this company | ₹65.71 Lakh (FY 2024) | •••• | •••• | •••• | Delhi, India | |
| American Vision Private Limited | ₹65.71 Lakh (FY 2016) | •••• | •••• | 19298.0% | •••• | Pune, Maharashtra, India |
| Shivvani Engineering Spares Private Limited | ₹65.7 Lakh (FY 2017) | •••• | •••• | •••• | Chennai, Tamil Nadu, India | |
| Cogent Tech Solutions Private Limited | ₹65.68 Lakh (FY 2025) | •••• | •••• | -9.0% | •••• | New Delhi, Delhi, India |
| Reshim Udyog Producer Company Limited | ₹65.67 Lakh (FY 2025) | •••• | •••• | 133.0% | •••• | Hingoli, Maharashtra, India |
| Defair Integrations Private Limited | ₹65.66 Lakh (FY 2023) | •••• | •••• | -71.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Q2 Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Q2 Pharma Private Limited
Q2 Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prity Kumari | Director | 24 Nov 2022 | 3 Years 10 Months | Current |
| Dipti Kumari | Director | 24 Nov 2022 | 3 Years 10 Months | Current |
| Vandana Jha | Director | 24 Nov 2022 | 3 Years 10 Months | Current |
Charges & Borrowings of Q2 Pharma Private Limited
Q2 Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Q2 Pharma Private Limited
Employment history and EPFO contributions of people linked to Q2 Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Q2 Pharma Private Limited
Q2 Pharma Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Dipti Kumari was appointed as Director on 24 Nov 2022.
Credit Ratings, Litigation & Regulatory Alerts for Q2 Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Q2 Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Q2 Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Q2 Pharma Private Limited
Q2 Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAACQ8693C1ZM | Bihar | Active | 31 Dec 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Q2 Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Q2 Pharma Private Limited
Q2 Pharma is an active private limited company based in Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 24 November 2022 (4+ years old) and is registered under CIN U24290DL2022PTC407366.
Q2 Pharma reported revenue of ₹65.71 Lakh for FY 2024.
Q2 Pharma has 3 current directors:
- Prity Kumari - Director
- Dipti Kumari - Director
- Vandana Jha - Director
Q2 Pharma reported a net profit of ₹7,392 (net margin 0.1%) and EBITDA of ₹7,392 (EBITDA margin 0.1%) for FY 2024, as per its filed financial statements.
The GSTIN of Q2 Pharma is 10AAACQ8693C1ZM, registered in Bihar.
The CIN (Corporate Identification Number) of Q2 Pharma is U24290DL2022PTC407366. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Q2 Pharma was incorporated on 24 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Q2 Pharma by revenue are Capsutab Drugs Private Limited, Samant Hospitech Private Limited, Salutary Softech Private Limited, Abkin Dealcomm Private Limited, Zatami Gourmet Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Dipti Kumari was appointed as Director on 24 Nov 2022. Prity Kumari was appointed as Director on 24 Nov 2022. Vandana Jha was appointed as Director on 24 Nov 2022.
The registered office of Q2 Pharma is at CO Chanchal Jha First Floor Khasra No.123 Gali No.13 Wazirabad, Delhi, India – 110084.
Q2 Pharma has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh.